Connect with us

Uncategorized

Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing

Aurora Cannabis Inc. (“Aurora” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 […]

The post Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing appeared first on Technical420.

Republished by Plato

Published

on

Aurora Cannabis Inc. (“Aurora” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

The Company has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 10% of the Offering to cover over-allotments, if any. This option may be exercised by the Underwriters for additional Units, Common Shares, Warrants or any combination of such securities.

The net proceeds of the offering will be used for general corporate purposes, which may include opportunistically reducing debt. The Company believes that the Offering fits with its broader strategy to have a strong balance sheet while maintaining maximum flexibility to invest and build towards being a leader in global cannabinoids.

The closing of the Offering is expected to take place on or about January 26, 2021 and will be subject to customary conditions, including approvals of the Toronto Stock Exchange and the New York Stock Exchange.

A prospectus supplement (the “Prospectus Supplement”) to the Company’s short form base shelf prospectus dated October 28, 2020 (the “Base Shelf Prospectus”) will be filed with the securities commissions or securities regulatory authorities in each of the provinces of Canada, except Quebec, and with the U.S. Securities and Exchange Commission (the “SEC”) as part of the Company’s registration statement on Form F-10 (the “Registration Statement”) under the U.S./Canada Multijurisdictional Disclosure System. The Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the proposed Offering. Prospective investors should read the Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement and the other documents the Company has filed for more complete information about the Company and this Offering before making an investment decision.

Copies of the Prospectus Supplement, following filing thereof, and the Base Shelf Prospectus will be available on SEDAR at www.sedar.com and copies of the Prospectus Supplement and the Registration Statement will be available on EDGAR at www.sec.gov . Copies of the Prospectus Supplement, following filing thereof, the Base Shelf Prospectus and the Registration Statement may also be obtained from BMO Capital Markets by contacting BMO Capital Markets, Brampton Distribution Centre C/O The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2 or by telephone at (905) 791-3151 Ext 431 or by email at torbramwarehouse@datagroup.ca or from BMO Capital Markets Corp., Attn: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, NY 10036 (Attn: Equity Syndicate), or by telephone at (800) 414-3627 or by email atbmoprospectus@bmo.com . Copies of such documents may also be obtained from ATB Capital Markets Inc., Attn: Gail O’Connor, 410-585 8th Ave SW, Calgary, Alberta, T2P 1G1, (403) 539-8629 or by email from atbcm_dealflow@atb.com .

No securities regulatory authority has either approved or disapproved of the contents of this press release. This press release is for information purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Aurora

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ‘71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com .

Aurora’s common shares trade on the TSX and NYSE under the symbol “ACB”, and is a constituent of the S&P/TSX Composite Index.

Further Information

For Media: For Investors:
Michelle Lefler ICR, Inc.
VP, Communications & PR Investor Relations
media@auroramj.com aurora@icrinc.com

Forward Looking Statements

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements “). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements made in this news release include statements regarding: the timing and completion of the Offering and the expected use of proceeds of the Offering. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora’s business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated September 24, 2020 (the “ AIF ”) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC’s website at www.edgar.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.


Primary Logo Source: https://technical420.com/cannabis-article/aurora-cannabis-inc-announces-us125-million-bought-deal-financing/

Uncategorized

New Jersey Cannabis Manufacturer License

The post New Jersey Cannabis Manufacturer License appeared first on Cannabis Industry Lawyer – Tom Howard.

Republished by Plato

Published

on

New Jersey Cannabis Manufacturer License

Last month New Jersey made history by signing three bills into law, finally regulating the use of recreational marijuana in the State, and becoming one of the 14 states to legalize the recreational use of cannabis for adults 21 and older.

Right now it’s not possible to buy recreational cannabis anywhere in New Jersey, however, experts say it will be at least six months before the first legal cannabis sale will take place in New Jersey.

So, now it’s the perfect time to start preparing for the endeavor. Take into consideration that the licensing application can be tricky and confusing, that’s why you should always contact a professional to help you with your application.

What is a New Jersey Cannabis Manufacturer License

A Class 2 Cannabis Manufacturer License is a legal document that allows its owner to process cannabis items in the State of New Jersey by purchasing or otherwise obtaining usable cannabis, manufacturing, preparing, and packaging cannabis items, and selling, and optionally transporting, these items to other cannabis manufacturers, cannabis wholesalers, or cannabis retailers, but not to consumers.

A New Jersey Cannabis Manufacturer License shall be issued by the Cannabis Regulatory Commission (CRC) for the premises at which the cannabis are going to be manufactured.

RELATED POST: NEW JERSEY CULTIVATION LICENSE

RELATED POST: MAP OF MARIJUANA LEGALITY BY STATE

How to apply for New Jersey Cannabis Manufacturer License

In order to apply for a Class 2 Cannabis Manufacturer License, the applicant must:

  • Apply for a license in the manner described in the latest legislation and the CRC;
  • Have at least one significantly involved person who has resided in this State for at least two years as of the date of the application, and provide proof that this person and any other person with financial interest who also has decision making authority for the cannabis manufacturer listed on an application submitted under the legislation is 21 years of age or older;
  • Meet the requirements of any rule or regulation adopted by the CRC;
  • Provide for each of the following persons to undergo a criminal history record background check: any owner, other than an owner who holds less than a five percent investment interest in the cannabis manufacturer or who is a member of a group that holds less than a 20 percent investment interest in the cannabis manufacturer and no member of that group holds more than a five percent interest in the total group investment, and who lacks the authority to make controlling decisions regarding the cannabis manufacturer’s operations; any director; any officer; and any employee.

According to the legislation, the CRC has to adopt rules and regulations that:

  • Provide for the annual renewal of the Class 2 Cannabis Manufacturer license;
  • Establish application, licensure, and renewal of licensure fees for cannabis manufacturers;
  • Require cannabis items manufactured by cannabis manufactures to be tested;
  • Require a cannabis manufacturer to meet any public health and safety standards, industry best practices, and all applicable regulations established by the commission related to the manufacturing of cannabis items;

In relation to the fees, the legislation requires that they comply with the following:

  • They shall be in the form of a schedule that imposes a greater fee for premises with more square footage; and
  • Shall be deposited in the “Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Fund”

A person who has been issued a license or conditional license shall display the license or conditional license at the premises at all times when cannabis items are being manufactured.

New Jersey Cannabis Manufacturer License Restrictions

For a period of 24 months after the effective date of the legislation it is unlawful for any owner, part owner, stockholder, officer, or director of any corporation, or any other person engaged in any retailing of any cannabis items to engage in the manufacturing of any cannabis items, or to own either whole or in part, or to be a shareholder, officer or director of a corporation or association, directly or indirectly, interested in any cannabis manufacturer.

This basically means that, if you own a cannabis dispensary in New Jersey, you won’t be able to have a controlling interest in any cannabis manufacturing operation.

During the first 24 months the holder of a Class 2 Cannabis Manufacturer License may hold one other license to operate another cannabis establishment, but it can’t be a Class 3 Cannabis Wholesaler License or a Class 5 Cannabis Retailer License.

Following that 24 month period  a cannabis license holder shall be authorized to hold a Class 1 Cannabis Cultivator License, a Class 2 Cannabis Manufacturer license, a Class 5 Cannabis Retailer license, and a Class 6 Cannabis Delivery license concurrently, provided that no license holder shall be authorized to concurrently hold more than one license of each class, except for an alternative treatment center that was deemed, during the 24 month period, to have an additional Class 5 Cannabis Retailer license for each satellite dispensary that was authorized and established by the alternative treatment center pursuant to the latest legislation These additional retailer licenses only permit the retail operation of each satellite dispensary, and shall not be replaced by any other class of cannabis establishment distributor, or delivery service license.

If you need more information about the licensing process, it is recommended that you contact an expert on the field so that you can get the necessary guidance in your endeavor.

RELATED POST: NEW JERSEY CANNABIS MICROBUSINESS LICENSE

RELATED POST: NEW YORK ADULT-USE DISTRIBUTOR

New-Jersey-Cannabis-Regulatory-Enforcement-Assistance-and-Marketplace-Modenization-Act-1

How to Apply for an Adult-Use New Mexico Cannabis License

How to Apply for an Adult-Use New Mexico Cannabis License The New Mexico Legislature is looking at legalizing cannabis for recreational use through a bill that was recently passed by two House committees.  The bill, sponsored by Reps. Javier Martinez, Andrea Romero,…

Thomas Howard

Thomas Howard

Cannabis Lawyer

Thomas Howard has been in business for years and can help yours navigate towards more profitable waters.

Water Soluble CBD

Water Soluble CBD might be the future of cannabis products.  Cannabis is widely accepted these days. Most states have legalized the medicinal use of cannabis, a lot of states have downright decided to legalize the adult-use of the plant as well. With the industry…

Nanotechnology in cannabis: What’s the benefit?

Nanotechnology in cannabis is one of the new trends in the industry: The last few years have been good for cannabis. With more states legalizing the plant, the public starting to –widely- accept the use of cannabis products, and the profits from the industry reaching…

How to get a Michigan Dispensary License

How to get a Michigan Dispensary License  A Michigan Dispensary License is a legal document that allows its holder to possess, store, test, sell, transfer purchase or transport marijuana to or from a marijuana establishment, whose primary aim would be to sell…

New York Small Business Cooperative License

New York Small Business Cooperative License New York may become the sixteenth state to legalize marijuana, as Gov. Cuomo renewed his vow to legalize marijuana in 2021. And considering the positive implications that this multi-millionaire industry may bring to the…

New York Cannabis Distributor License

New York Cannabis Distributor License New York lawmakers created an adult-use distributor license for those interested in starting a cannabis business to get in the industry. After Bill S854 was presented New York is on its way to becoming one of the sixteenth states…


316 SW Washington Street, Suite 1A
Peoria, Illinois 61602

Phone: (309) 740-4033 || Email:  tom@collateralbase.com


316 SW Washington Street, Suite 1A
Peoria, Illinois 61602

Phone: (309) 740-4033 || Email:  tom@collateralbase.com

cannabis industry lawyer

316 SW Washington St,Peoria,
IL 61602, USA
Call Us (309) 306-1095 || e-Mail Us tom@collateralbase.com

Checkout PrimeXBT
Trade with the Official CFD Partners of AC Milan
The Easiest Way to Way To Trade Crypto.
Check out Nord
Make your Money Grow with Mintos
Source: https://www.cannabisindustrylawyer.com/new-jersey-cannabis-manufacturer-license/

Continue Reading

Uncategorized

New Jersey Cultivation License

The post New Jersey Cultivation License appeared first on Cannabis Industry Lawyer – Tom Howard.

Republished by Plato

Published

on

New Jersey Cultivation License

After years of failed attempts, last month three bills were signed into law, permitting and regulating the use of recreational marijuana in New Jersey, becoming one of the 14 states to legalize the recreational use of cannabis for adults 21 and older.

Right now it’s not possible to buy recreational cannabis anywhere in New Jersey, however, experts say it will be at least six months before the first legal cannabis sale will take place in New Jersey.

So, now it’s the perfect time to start preparing for the endeavor. Take into consideration that the licensing application can be tricky and confusing, that’s why you should always contact a professional to help you with your application.

What is a New Jersey Cultivation License

A Class 1 Cultivator License is a legal document that allows its owner to grow, cultivate, or produce cannabis in the state of New Jersey, as well as sell and transport this cannabis to other cannabis cultivators, or usable cannabis to cannabis manufacturers, cannabis wholesalers or cannabis retailers but not to consumers.

A cannabis Cultivation License shall be issued by the Cannabis Regulatory Commission (CRC) for the premises at which the cannabis is grown or cultivated.

RELATED POST: HOW TO OPEN A DISPENSARY IN NEW JERSEY

RELATED POST: MAP OF MARIJUANA LEGALITY BY STATE

How to apply for New Jersey Cultivation License

In order to apply for a Class 1 Cultivation License, the applicant must:

  • Apply for a license in the manner described in the latest legislation and the CRC;
  • Have at least one significantly involved person who has resided in this State for at least two years as of the date of the application, and provide proof that this person and any other person with financial interest who also has decision making authority for the cannabis cultivator listed on an application submitted under the legislation is 21 years of age or older;
  • Meet the requirements of any rule or regulation adopted by the CRC;
  • Provide for each of the following persons to undergo a criminal history record background check: any owner, other than an owner who holds less than a five percent investment interest in the cannabis cultivator or who is a member of a group that holds less than a 20 percent investment interest in the cannabis cultivator and no member of that group holds more than a five percent interest in the total group investment, and who lacks the authority to make controlling decisions regarding the cannabis cultivator’s operations; any director; any officer; and any employee.

If you need more information about the licensing process, it is recommended that you contact an expert on the field so that you can get the necessary guidance in your endeavor.

About the Grow Canopies for the New Jersey Cultivation Licensees

Pursuant to the latest legislation on the matter, the commission shall adopt rules or regulations restricting the size of mature cannabis plant grow canopies at premises for which a license has been issued to a cannabis licensee. In this sense, when adopting rules and regulations the CRC has to consider whether:

  • Limit the size of mature cannabis plant grow canopies for premises where cannabis is grown outdoors and for premises where cannabis is grown indoors in a manner calculated to result in premises that produce the same amount of harvested cannabis leaves and harvested cannabis flowers, regardless of whether the cannabis is grown outdoors or indoors; or
  • Adopt a tiered system under which the permitted size of a cannabis cultivators’ mature cannabis plant grow canopy may increase or decrease at the time of licensure renewal in accordance with that tiered system, except that the permitted size of a cannabis cultivator’s mature cannabis plant grow canopy may not increase following any year during which the commission disciplined the cannabis cultivator for violating a provision, rule or regulation provided by the legislature; or
  • Take into consideration the market demand for cannabis items in this State, the number of persons applying for a license and to whom a license has been issued pursuant to those sections, and whether the availability of cannabis items in this State is commensurate with the market demand.

New Jersey Cultivation License Restrictions

At this time, the total number of licenses that will be available in New Jersey has not been determined. However, the current legislation limits New Jersey cultivation licenses to 37 over the first 24 months, which includes any alternative treatment centers deemed to be eligible for a New Jersey Cultivation license. However, this limitation does not apply to cannabis cultivator licenses issued to microbusinesses

Further, for a period of 24 months after the effective date of the legislation it is unlawful for any owner, part owner, stockholder, officer, or director of any corporation, or any other person engaged in any retailing of any cannabis items to engage in the growing of, testing of manufacturing of, wholesaling of, or transporting in bulk any cannabis items, or to own either whole or in part, or to be a shareholder, officer or director of a corporation or association, directly or indirectly, interested in any cannabis cultivator.

This basically means that, if you own a cannabis dispensary in New Jersey, you won’t be able to have a controlling interest in any cannabis cultivation operation.

Finally, at least 10 percent of the total number of licenses and conditional licenses shall be designated for and only issued to microbusinesses. After the initial period during which the number of licenses is capped, the commission shall review the current number of licenses issued and, provided there exist qualified applicants, the commission shall issue a sufficient number of licenses to meet the market demands of the State of New Jersey.

RELATED POST: NEW YORK SMALL BUSINESS COOPERATIVE LICENSE

RELATED POST: NEW YORK ADULT-USE DISTRIBUTOR

New-Jersey-Cannabis-Regulatory-Enforcement-Assistance-and-Marketplace-Modenization-Act-1

How to Apply for an Adult-Use New Mexico Cannabis License

How to Apply for an Adult-Use New Mexico Cannabis License The New Mexico Legislature is looking at legalizing cannabis for recreational use through a bill that was recently passed by two House committees.  The bill, sponsored by Reps. Javier Martinez, Andrea Romero,…

Thomas Howard

Thomas Howard

Cannabis Lawyer

Thomas Howard has been in business for years and can help yours navigate towards more profitable waters.

Water Soluble CBD

Water Soluble CBD might be the future of cannabis products.  Cannabis is widely accepted these days. Most states have legalized the medicinal use of cannabis, a lot of states have downright decided to legalize the adult-use of the plant as well. With the industry…

Nanotechnology in cannabis: What’s the benefit?

Nanotechnology in cannabis is one of the new trends in the industry: The last few years have been good for cannabis. With more states legalizing the plant, the public starting to –widely- accept the use of cannabis products, and the profits from the industry reaching…

How to get a Michigan Dispensary License

How to get a Michigan Dispensary License  A Michigan Dispensary License is a legal document that allows its holder to possess, store, test, sell, transfer purchase or transport marijuana to or from a marijuana establishment, whose primary aim would be to sell…

New York Small Business Cooperative License

New York Small Business Cooperative License New York may become the sixteenth state to legalize marijuana, as Gov. Cuomo renewed his vow to legalize marijuana in 2021. And considering the positive implications that this multi-millionaire industry may bring to the…

New York Cannabis Distributor License

New York Cannabis Distributor License New York lawmakers created an adult-use distributor license for those interested in starting a cannabis business to get in the industry. After Bill S854 was presented New York is on its way to becoming one of the sixteenth states…


316 SW Washington Street, Suite 1A
Peoria, Illinois 61602

Phone: (309) 740-4033 || Email:  tom@collateralbase.com


316 SW Washington Street, Suite 1A
Peoria, Illinois 61602

Phone: (309) 740-4033 || Email:  tom@collateralbase.com

cannabis industry lawyer

316 SW Washington St,Peoria,
IL 61602, USA
Call Us (309) 306-1095 || e-Mail Us tom@collateralbase.com

Checkout PrimeXBT
Trade with the Official CFD Partners of AC Milan
The Easiest Way to Way To Trade Crypto.
Check out Nord
Make your Money Grow with Mintos
Source: https://www.cannabisindustrylawyer.com/new-jersey-cultivation-license/

Continue Reading

Uncategorized

Will Canopy Growth Be Able To Capitalize On Mexico Once Cannabis Is Legalized?

According to former Mexican President Vicente Fox, legal recreational cannabis could be legal in Mexico by next week. Mexico has a great climate for cultivating cannabis and it could be one of the world’s largest cannabis markets. During the last year, we have seen an influx in the number of companies that are focused on […]

The post Will Canopy Growth Be Able To Capitalize On Mexico Once Cannabis Is Legalized? appeared first on Technical420.

Republished by Plato

Published

on

According to former Mexican President Vicente Fox, legal recreational cannabis could be legal in Mexico by next week.

Mexico has a great climate for cultivating cannabis and it could be one of the world’s largest cannabis markets. During the last year, we have seen an influx in the number of companies that are focused on the Mexican cannabis market and this is a trend that our readers should be aware of.

Canopy Growth Corporation (WEED.TO) (CGC) is the largest global cannabis company and has the most market share in Canada. The company is backed by Constellation Brands (STZ) which owns the Corona beer brand. Constellation has invested more than $4 billion into Canopy Growth and we are favorable on the infrastructure that Constellation has in Mexico.

Due to the nature of the relationship with Constellation Brands, Canopy Growth would have a significant amount of infrastructure in Mexico as soon as the plant is declared to be legal and we expect it to be a major beneficiary of a change in legislation.

The bill that Fox is referring to is backed by the administration of President Andres Manuel Lopez Obrador. The passing of the legislation would mark a major shift in a country that has been negatively impacted by violence between drug cartels.

Fox has been a long-standing advocate for the decriminalization of cannabis in Mexico and we are favorable on how he has supported the sector. He told Reuters that he is receiving direct information from the lawmakers that is considered to trustworthy and we expect legalization to be a major catalyst for the cannabis industry.

According to a study that was conducted by Grand View Research, the global legal market for cannabis could be worth $73.6 billion by 2027. With markets like Mexico advancing legal cannabis legislation, we believe the size of the cannabis market could be larger than what Grand View predicts and will monitor how the sector evolves from here.

Over the next year, we expect to see large-scale US and Canadian cannabis operators expand into Mexico and this is a trend that our readers need to be aware of. If you want to learn more about the companies like Aurora Cannabis which are trying to capitalize on the Mexican medical cannabis market, please send an email to support@technical420.com with the subject “Mexican Cannabis Companies” to be added to our distribution list.

Share Share - Facebook Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Checkout PrimeXBT
Trade with the Official CFD Partners of AC Milan
The Easiest Way to Way To Trade Crypto.
Check out Nord
Make your Money Grow with Mintos
Source: https://technical420.com/cannabis-article/will-canopy-growth-be-able-to-capitalize-on-mexico-once-cannabis-is-legalized/

Continue Reading
Heartland5 days ago

Why CBD is a Great Partner for Any Wellness Routine

Heartland5 days ago

Remove Limonene from oil

Heartland4 days ago

Heartland4 days ago

CBD and Depression

Metal5 days ago

CISA mills’ daily steel output up 0.85% in late Feb after 3.49% rise in mid-Feb

Heartland5 days ago

Columbia Care Guides Higher For 2021

Metal4 days ago

India’s AMNS inks MoU with Odisha government for greenfield mill project

News3 days ago

CBD News Roundup: CBD Leader Charlotte’s Web to Sell THC Products

Heartland5 days ago

Hulled Hemp Seeds Market Estimated Forecast Analysis 2021-2030

Uncategorized5 days ago

Namaste Technologies Announces Appointment of New CFO

Metal5 days ago

Turkish coated coil prices surge amid good demand, limited allocation

News4 days ago

CBD News: CBD giant Charlotte’s Web positions to enter THC market

Heartland4 days ago

Sudden rise in anxiety

Manufacturing4 days ago

Confused with these similar quotes from different companies. Could it be the same company? Am I being scammed in any way?

Uncategorized4 days ago

New Jersey Cultivation License: How to Apply

Heartland3 days ago

Durag and the Deertag Ep 37: Thanos Dust with Jay Simpson

Composites5 days ago

New postponement sees JEC World moved to 2022

Metal5 days ago

AISI calls on new US commerce secretary to maintain Section 232

Heartland4 days ago

CBDA: A Complete Introduction to Cannabidiolic Acid (CBDA)

Heartland4 days ago

Uncategorized17 hours ago

Can CBD Oil Help Treat Medical Conditions?

Metal5 days ago

Ex-China HDG offers rise further, better local market brings optimism

Heartland5 days ago

Cannabis Companies Go On Buying Spree

Manufacturing3 days ago

Why are warehouse break buzzers so expensive??

Uncategorized2 days ago

Cannabis Market Could Reach $90 Billion By 2026

Heartland5 days ago

Hulled Hemp Seeds Market Estimated Forecast Analysis 2021-2030

Heartland4 days ago

Heartland4 days ago

Meet GABRIELLA

Material3 days ago

In situ deposition of NiO nano particles on cotton fabric using sol–gel method- photocatalytic activation properties

Heartland3 days ago

The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review

Trending

A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America